Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
KOBE, Aug. 8/Kyodo JBN- AsiaNet/--
Carna Biosciences, Inc. ("Carna") is pleased to announce the signing of a collaborative agreement with
Caliper Life Sciences, Inc. USA ("Caliper") on August 6 (US Eastern Daylight Time). Carna will supply a
set of discrete protein kinases aiding the expansion of Caliper's kinase profiling and assay development
services, and ProfilerPro Kinase Selectivity Assay Kits. Caliper's products and services are widely used
and highly regarded by leading pharmaceutical and biotech companies. The selection of Carna as a
Preferred Provider enhances the visibility and use of Carna's products in the area of kinase inhibitor drug
discovery - a major focus of targeted therapy in the areas of cancer, neurological, and autoimmune
diseases.
"I am proud of the expression and purification technologies that Carna has developed in order to produce
nearly 300 human kinases to date, and even more pleased that Caliper has selected Carna Biosciences
as a principle supplier for Caliper's ProfilerPro Kits," said Kohichiro Yoshino, President and CEO of Carna
Biosciences. "Caliper is an established and reliable partner to the pharmaceutical and biotech industry.
Working with Caliper provides Carna with access to a wealth of new opportunities to expand sales of
protein kinases throughout the worldwide market. This synergistic impact of combining Caliper's advanced
instrumentation with the wide selection and premier quality reagents provided by Carna will greatly benefit
both companies and their clients. We anticipate that this expanded relationship with Caliper will further
position us to explore R&D Partnerships with global biopharmaceutical companies.
About Carna Biosciences, Inc.
Carna Biosciences, Inc. (www.carnabio.com), founded in April 2003, is a Japanese biotechnology
company conducting intercellular signaling-based drug discovery programs, as well as providing drug
discovery services to pharmaceutical companies, using proprietary technologies in gene cloning, active
kinase protein expression, protein purification and homogeneous assay development.
The company provides products and services including protein kinases, profiling and screening services,
assay development services and crystallography products and services.
About Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. (www.caliperls.com) is a premier provider of cutting-edge technologies enabling
researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests
more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between
in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's
portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical
imaging technologies, and discovery & development outsourcing solutions.
Source: Carna Biosciences, Inc.
Contact:
Tomohisa Yamazaki,
Manager
Corporate Planning
Carna Biosciences, Inc.
Phone: +81-78-302-7039
Fax: +81-78-302-6665
E-mail: ir-team@carnabio.com
NEWS 
